Treatment Goals
March 8, 2013
THE Skin & Cancer Foundation,
together with a multidisciplinary
group of leading healthcare
professionals, has developed the
first Australian Treatment Goals for
chronic plaque psoriasis.
Published in the Australasian
Journal of Dermatology, the Goals’
recommendations highlight the
need for Australian clinicians to
align with globally recognised best
practice by taking into account the
high incidence of co-morbidities,
significant impact on quality of life
and patient dissatisfaction with
treatment (using the Dermatology
Quality of Life Index and the
Psoriasis Area and Severity Index).
“Improving treatment outcomes
and patient quality of life are the
main objectives of the Treatment
Goals,” said Associate Professor
Chris Baker, a member of the
Steering Committee behind the
Treatment Goals.
“The next challenge to give effect
to the Treatment Goals is to
encourage their day to day use in
treatment decision making.
“To achieve best practice when
treating patients with moderate to
severe psoriasis, the Treatment
Goals highlight the need for
revision to the current PBS criteria
for psoriasis therapies,” he added.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Mar 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Mar 13
